Dr. Jennifer Thi Wing Krall, MD

Dr. Krall practices at Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina.

Dr. Krall's NPI, 1437577954, was assigned on April 1, 2014. Dr. Krall holds North Carolina license 2019-02191.

Dr. Krall's primary practice is Davie Surgery - Ophthalmology - HOPD, at 329 Nc Highway 801 N, Bermuda Run, NC 27006.

Dr. Krall's primary practice is Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina. Dr. Krall is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Atrium Health Wake Forest Baptist. Dmand AI also links Dr. Krall to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Krall practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Krall's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Krall is licensed in North Carolina.

CMS data shows 126 Medicare services from Dr. Krall across 4 procedure codes in 2024, for 97 Medicare patients. Medicare paid $14,867 for them.

CMS counts 97 Medicare patients who saw Dr. Krall in 2024. The largest group is 65 to 74, with 35 patients. 72% of them have high blood pressure, and 67% have high cholesterol. 28% are also on Medicaid. Their average risk score is 3.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Krall's median patient age at 70, with 56% women.

In 2024, Dr. Krall wrote 801 Medicare Part D claims for 92 patients. 39% of them were for generic drugs. CMS names the drug for 715 of them, across 24 drugs with 11 or more claims each, at $1,705,646 in total drug cost. In 2023, CMS named 587 claims across 20 drugs.

Dr. Krall accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Krall as offering telehealth.

Dmand AI links 7 papers to Dr. Krall, published from 2019 to 2025. The most frequent topics are Mice, Inbred C57BL, Muscle, Skeletal and Acute Lung Injury. Dr. Krall has published most often in Chest. Dr. Krall's most frequent co-authors are Daniel Clark Files, MD, Kevin Ward Gibbs and Michael James Toth, DO, MS.

CMS Open Payments shows 3 general payments to Dr. Krall from 3 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 54% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $138.